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Abstract 
Two simple, accurate and precise spectrophotometric methods have been developed for the 
simultaneous estimation of Amoxicillin and Dicloxacillin. Method A was quantitative determination of 
Amoxicillin and Dicloxacillin by First Order Derivative zero crossing method. The first order derivative 
absorption at 231.02 nm (zero cross point of Dicloxacillin) was used for Amoxicillin and 246.26nm (zero cross 
point of Amoxicillin) for Dicloxacillin. Both the drugs obeyed the limit 15-35µg/ml (correlation coefficient 
r2<1). No interference was found between the both determined constituents and those of matrix. Method B was 
developed for estimation of content uniformity of Amoxicillin and Dicloxaciliin in its combined tablet dosage 
form. The method involves solving the simultaneous equation using 245nm and 227nm as two wavelengths for 
Amoxicillin and Dicloxacillin respectively. From the results, it was concluded that all brands are within the 
limits of content uniformity (85-115%). 0.1 N sodium hydroxide was used as a solvent for both methods. 
Developed method was employed to determine the Amoxicillin and Dicloxacillin content in ten individual 
capsule units of four marketed formulations. Both the methods were validated statistically and recovery studies 
were carried out to confirm the accuracy of the methods.  
Keywords: Amoxicillin, Dicloxacillin, First Derivative Spectroscopy, Content Uniformity, Simultaneous 
equation method. 
 
1. Introduction 
Amoxicillin (AMC) is oral semi synthetic 
amino penicillin similar to ampicillin. It is more 
stable to gastric acids and more bioavailable than 
other penicillin’s and is a moderate-spectrum, 
bacterolytic, β-lactam antibiotic used to treat bacterial 
infections, skin infections, urinary tract infections 
caused by susceptible micro organisms. It is 
chemically 6-[D-(-)-α-amino-p-hydroxy 
phenylacetamido) pencillanic acid]. Literature survey 
reveals that several analytical methods have been 
reported for the quantitative determination of AMC 
individually in pharmaceutical formulations or in 
combination or in biological fluids and they are 
HPLC1,2, UV3, Bioanalytical method4,5, 
Spectrophotometry6,7, Simultaneous 
Spectroscopy8,9,10, Second order multivariate 
analysis11, LC-MS/MS12, LC-ESI-MS13.  
Dicloxacillin (DIC) is a narrow – spectrum β 
lactam antibiotic of the penicillin class. It is 
chemically (2S, 5R, 6R)-6-[(3-(2, 6-dichlorophenyl)-
5-methyl-oxazole-4-carbonyl) amino]-3, 3-dimethyl-
7-oxo-4-thia-1-azabicyclo (3.2.0) heptanes-2-
carboxylic acid. It acts by inhibiting the synthesis of 
bacterial cell walls and active against β-lactamase 
producing organisms such as Staphylococcus aureas. 
It is used to treat infections caused by susceptible 
gram-positive bacteria. Literature survey reveals that 
it is official in United States Pharmacopoeia. Several 
analytical methods have been reported for the 
quantitative determination of DIC individually in 
pharmaceutical formulations or in combination and 
they are HPLC14,15 and Spectroscopy16. The 
developed methods were more precise with 0.1N 
NaOH as solvent. The first derivative and content 
uniformity was determined at less linearity range. 
 
2. Materials and methods 
 2.1. Instrumentation 
Analysis was performed on double beam 
UV/Visible spectrophotometer (LABINDIA UV 
3092) having two matched quartz cells with 1 cm path 
length. Weighing electronic balance (Shimadzu 
Model No EPA-151 WT -12) was used. 
2.2. Reagents 
Sodium hydroxide (0.1N NaOH): 4 gm of 
sodium hydroxide was dissolved in distilled water and 
made up to 1000 ml.  
Four brands of Amoxicillin and Dicloxacillin 
combination capsules (250-250mg) are NOVACLOX 
(Mfg by Cipla), STARCLOX (Mfg by Invision Medi 
sciences Pvt Ltd.), BAMICILLIN (Mfg by Cruisa 
Pharmacia Pvt Ltd.), and AMPOXIN PLUS (Mfg by 
Unichem)  
2.3. Standard stock solution (Amoxicillin & 
Dicloxacillin) 
Standard stock solutions of AMC and DIC 
(1000µg/ml) were prepared by dissolving and diluting 
with 0.1 N NaOH and were further diluted with 0.1N 
NaOH to obtain final concentration of 100 µg/ml 
(working standard solution). 
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3. Results and Discussion 
3.1. Method A: First Derivative Spectroscopy 
Suitable aliquot of standard stock solutions 
were diluted with 0.1N NaOH to obtain a 
concentration of 25 µg/ml and scanned in the range of 
200-400 nm. The absorption spectra thus obtained 
were derivatized to first order. From the over line 
spectra of both the drugs (fig.1) wavelength was 
selected for quantization which is 231.02 nm (zero 
cross point of DIC) for AMC and 246.26 nm (zero 
cross point of AMC) for DIC. 
Linearity for both the drugs was obtained in 
the concentration range of 15-35 µg/ml.  For all the 
solutions the derivative spectra were obtained over 
200-400 nm range. At 231.02 nm there were well 
developed first order derivative absorption spectra for 
varying concentrations of AMC for its 
determination(fig.2a) and no interference was 
observed with DIC as D1=0 (fig 2b). So any change 
in DIC concentration has no effect on quantitative 
determination of AMC. 
To determine DIC the first order derivative 
spectra were used by making measurements at 246.26 
nm (fig.3a) at which D1=0 for AMC. No interference 
was observed with AMC at different concentrations 
(fig.3b) for quantitative determination of DIC. Over 
line spectra of both the drugs were given in (fig.4) 
The calibration curves were constructed by plotting 
drug concentration versus absorbance values of first 
derivative spectrum (D1) 231.02nm for AMC and 
246.26 nm for DIC. Statistical data for calibration 
curves is depicted in (Table 1). The concentrations of 
individual drugs present in the mixture were 
determined from the calibration curves in 
quantization mode. 
Fig 1: First order derivative overlain spectra of 
Amoxicillin (AMC, 25 µg/ml) and Dicloxacillin 
(DIC, 25 µg/ml) 
 
Fig 2a: First order derivative spectra for AMC 
(20, 25, 30, 35 µg/ml) and at 246.26 nm 
 
Fig 2b: First order derivative spectra for AMC (25 
µg/ml) and DIC (20, 25, 30, 35µg/ml) 
 
Fig 3a: First order derivative spectra for DIC (20, 
25, 30, 35 µg/ml) and at 231.02nm 
 
Fig 3b: First order derivative spectra for DIC (25 
µg/ml) and AMC (20, 25, 30, 35µg/ml) 
 
Fig 4: First order derivative spectra of (a) 20, (b) 
25, (c) 30, and (d)35 µg/ml  solution of AMC and  
(w) 20, (x) 25, (y) 30, and (z)35 µg/ml  solution of 
DIC 
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3.1.1. Sample preparation 
10 tablets were weighed accurately; average 
weight was determined and finely powdered. The 
powder equivalent to 10 mg of AMC and 10 mg of 
DIC were weighed accurately and transferred to 100 
ml volumetric flask and diluted with 0.1N sodium 
hydroxide solution. The solution was filtered through 
whatman filter paper (no.41) and the volume was 
adjusted up to the mark with 0.1N NaOH. 25µg/ml of 
AMC and DIC were prepared with 0.1N NaOH .The 
concentration of both AMC and DIC were determined 
by measuring the absorbance at 231.02nm and 246.26 
nm in first order spectrum mode and the results of 
tablets analysis were calculated from the calibration 
curve in quantization mode.  
3.1.2. Validation 
The method was validated statistically as per 
ICH/ USP 16 guidelines for all the parameters like 
accuracy, linearity, precision, ruggedness and 
specificity. Accuracy of the method was ascertained 
on the basis of recovery studies, carried out by 
standard addition method, in which pre-analyzed 
samples were taken and standard drug was added at 
three different levels (80%,100%,120% of the test 
concentration).The % recovery±SD lies in the range 
of 99.28±0.302 to 99.72±0.52 for AMC and 
99.39±0.62 to 100.05±0.532 for DIC (Table2).The 
linearity of the method was established from the first 
derivative spectra by the measurement of absorbance 
of standard solutions containing varying 
concentrations of each compound in the presence of 
constant concentrations of other one. Linearity was 
constructed in the range of (15-35 µg/ml) (r2<1). 
Precision was studied by analyzing six replicates of 
sample solutions and concentrations were 
calculated.Ruggednesss was established by carrying 
out the experiment at different conditions like intra-
day, inter-day and by different analyst. Specificity of 
the method was ascertained by analyzing standard 
drug sample. There was no interference of the 
excipients present in the formulation. By observing 
validation parameters (Table 3), the method described 
was found to be specific, accurate, precise, and 
economical, can be successfully applied to analyze 
commercially available tablets contains AMC  and 
DIC. The results obtained were in good agreement 
with the labeled content (Table 4). 
Table 1: Statistical Data of Calibration Curve. 
S.No Parameters AMC DIC 
1 Wave length(nm) 231.02 246.26 
2 Beers law limit 15-35 15-35 
3 Regression equation* Y=0.001X Y=0.001X 
4 Correlation coefficient 0.998 0.997 
5 LOD(µg/ml) 10 15 
6 LOQ(µg/ml) 15 20 
Y=mx; where x is the concentration of drug in µg/ml; y is the amplitude at specific wavelength, m is the slope. 
Table 2: Recovery Study Data 
S.No Level of standard addition (%) % Recovery ±SD* 
 AMC DIC 
1 80 99.28±0.302 99.39±0.62 
2 100 99.87±0.38 100.10±0.55 
3 120 99.72±0.52 100.05±0.532 
 
Table 3: Result of Validation Studies of Proposed Method 
S.No Parameters AMC DIC 
1 Linearity ± 15% of test conc. ± 15% of test conc. 
2 Precision  
(%label claim ± SD,n=5) 
99.9 ± 0.32 100.05 ± 0.532 
Ruggedness 
(%label claim,n=3) 
 
3 Intra day 100.10 99.28 
4 Inter day 99.85 100.05 
5 Different analyst 99.50 99.75 
6 Specificity Specific & passes Specific & passes 
SD is standard deviation 
Table 4: Results of Analysis of Commercial Formulations  
S. No Drug % Label Claim*(mg) ± SD* 
1 AMC 99.50 0.325 
2 DIC 99.90 0.510 
*mean of three determinations. SD is standard deviation. 
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3.2. Method B: Simultaneous equation in 
application to content uniformity 
3.2.1. Sample preparation (Amoxicillin and 
Dicloxacillin) 
10 tablets were individually dissolved in 30 
ml of 0.1 N NaOH, further diluted to 250 ml with 0.1 
N NaOH solutions and was filtered using sintered 
glass filter. From the filtrate, 25µg/ml was prepared 
with 0.1 N NaOH. 
3.2.2. Procedure: 
Analytical wave length for simultaneous 
equation method, was selected by preparing standard 
solutions of AMC (25 µg/ml) and DIC (25 µg/ml) 
scanned in UV range (fig.5) represents the overlain 
spectrum of both the drugs. The wavelengths of AMC 
and DIC for simultaneous equation were 245 nm and 
227 nm respectively. 
Working standard solutions (100µg/ml) of 
both the drugs were diluted to prepare solutions 
having concentrations 15, 20, 25, 30, 35µg/ml of 
AMC and DIC. All the solutions were measured at 
both the wavelengths and four calibration curves were 
constructed. 
  Absorptivities at each wavelength for AMC 
and DIC were determined and used to form the 
equation. The absorbance and absorptivity values at 
particular wavelengths were submitted in the 
following equations to obtain concentration. 
       
        Cx = (A2ay1-A1ay2)/ (ax2ay1-ax1ay2)  
CY = (A1ax2-A2ax1)/ (ax2ay1-ax1ay2) 
CX = concentration of Amoxicillin. 
Cy = concentration of Dicloxacillin. 
A1=absorbance of samples at 245nm. 
A2= absorbance of samples at 227 nm. 
ax1 is the absorbivity of Amoxicillin at 245nm. 
ax2 is the absorbivity of Amoxicillin at 227 nm. 
ay1 is the absorbivity of Dicloxacilin at 245nm. 
ay2 is the absorbivity of Dicloxacilin at 227 nm. 
 
Absorptivity of DIC at 245 nm (ay1) and 
227 nm (ay2) was found to be 184.4 and 204 
respectively. Absorptivity of AMC at 245 nm (ax1) 
and 227 nm (ax2) was found to be 271.2 and 68 
respectively. 
Fig.5: Overlain spectra of Amoxicillin (AMC) 
and Dicloxaciliin (DIC) 
 
3.2.3. Validation parameter 
Linearity was obtained in the range of (15-35 
µg/ml) for AMC and DIC .The developed method 
was validated by determing accuracy, precision and 
repeatability. For the determination of intraday 
precision, solutions contains AMC and DIC in the 
range of 15-25 µg/ml were analyzed  6 times on the 
same day and % CV was calculated. For inter day 
precision, same range was analyzed on 3 different 
days and % CV was calculated. Repeatability was 
determined by analyzing 3 concentrations of the 
calibration curve, prepared in triplicate and % CV 
was calculated and given in (Table 5). Accuracy of 
analysis was determined by calculating percentage 
recovery of combination of AMC and DIC by 
standard addition method. 
To a fixed amount of sample solution, 
increasing aliquots of mixture of standard stock 
solution (1.5, 2.0 & 2.5 ml) was spiked and diluted to 
10 ml with water. The solutions were measured at 227 
& 245 nm and % recovery of DIC and AMC was 
calculated. 
Four different brands of AMC and DIC were 
analyzed for their content uniformity. Content of 
individual tablet unit (10 replicates) for all 
formulations were calculated using simultaneous 
equation method. None of the results fall outside the 
prescribed range i.e. 85-115%. The results for all four 
brands complied with pharmacopoeia requirements. 
The corresponding data along with % content of both 
the combinations are given in (Table 6).The method 
can be used for routine quality control of dosage form 
in industry. 
 
Table 5.Validation parameters for AMC and DIC 
 
S.NO Parameter Results of DIC Results of AMC 
1 Correlation coefficient(r2) 227 nm 
0.998 
245nm 
0.999 
227nm 
0.997 
245nm 
0.998 
2 Linearity range (µg/ml) 15-35 15-35 
3 Precision  
a Repeatability(n=3)(%CV) 0.35-0.75 0.55-0.88 
b Intraday(n=5) (%CV) 0.92-1.20 0.77-0.97 
c Interday(n=5) (%CV) 1.30-1.70 1.01-1.65 
4 Mean % Recovery  100.21-100.05 99.99-100.25 
 
 
 
Research Article                                                                          Nagamalleswari et al /2014 
 
57 
 
Table 6: Percentage content of AMC and DIC in different brand formulations 
Tablet   Number A B C D 
  Diclox Amox Diclox Amox Diclox Amox Diclox 
1 90.90 95.60 91.05 96.50 97.50 95.50 98.90 91.50 
2 91.20 94.90 92.50 95.30 96.20 96.25 99.10 92.05 
3 90.30 94.10 91.90 96.20 96.90 95.90 98.20 91.40 
4 89.90 96.20 92.30 97.10 95.90 96.50 99.50 92.50 
5 90.80 94.90 90.90 96.90 95.50 94.20 99.90 91.10 
6 92.30 93.90 91.20 96.50 96.20 94.00 100.05 92.10 
7 91.45 94.90 93.50 95.90 96.40 94.50 98.10 91.60 
8 92.45 96.20 91.90 96.10 96.70 93.90 98.20 91.90 
9 90.30 97.10 92.10 96.30 95.20 96.90 99.50 92.50 
10 91.00 97.05 91.50 95.10 95.30 94.30 100.10 92.60 
Average 91.06 95.48 91.886 96.19 96.18 95.19 99.13 91.92 
SD 0.832 1.128 0.780 0.633 1.510 1.139 0.728 0.513 
%CV 0.914 1.181 0.849 0.658 1.570 1.197 0.734 0.550 
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